Clinical Trial 51396

Evergreen Park, IL 60805


This study aims to assess the efficacy, safety, and tolerability of itepekimab in chronic obstructive pulmonary disease (COPD) patients.

  1. Must be 40-85 years of age at the time of consent
  2. Former Smoker or have quit smoking within the last 6 months before consenting to the study
  3. Must have had at least 1 COPD flare-up in the last 12 months and prescribed a steroid (i.e.: prednisone, Solu-Medrol, and or an antibiotic)
  4. Must have used maintenance inhalers for greater than 3 months prior to consenting to the study
  5. Willing to sign an informed consent to participate in the study

Qualified Participants May Receive:

  1. $100 per completed study visit up to 31 clinic visits
  2. Study visit transportation at no cost to you
  3. Medical treatment at no cost to you

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.